Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy

There is a Blood Commentary on this article in this issue.

Guardat en:
Dades bibliogràfiques
Publicat a:Blood
Autors principals: Pemmaraju, Naveen, Kantarjian, Hagop, Nastoupil, Loretta, Dupuis, Megan, Zhou, Lisa, Pierce, Sherry, Patel, Keyur P., Masarova, Lucia, Cortes, Jorge, Verstovsek, Srdan
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2019
Matèries:
Letter to Blood
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6634962/
https://ncbi.nlm.nih.gov/pubmed/30796023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2019-01-897637
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars